ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma

Annals of hematology

Volumn 93, Issue 10, 2014, Pages 1745-1753

  Labrador, Jorge ^a   Cabrero Calvo, Mónica ^a   Pérez López, Estefanía ^a   Mateos, María Victoria ^a   Vázquez, Lourdes ^a   Caballero, María Dolores ^a   García Sanz, Ramón ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYTARABINE; ETOPOSIDE; MELPHALAN; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; AGED; AUTOTRANSPLANTATION; CHILD; DRUG SCREENING; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RETROSPECTIVE STUDY; SALVAGE THERAPY; SCINTISCANNING; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CHILD; CISPLATIN; COMBINED MODALITY THERAPY; CYTARABINE; DRUG EVALUATION; ETOPOSIDE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL MOBILIZATION; HODGKIN DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MELPHALAN; METHYLPREDNISOLONE; MIDDLE AGED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85027946093     PISSN: None     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2114-0     Document Type: Article

References (0)